|
APUA
Legislative Developments
6/24/2008 APUA
submits a statement of support at the Senate hearing: "Emergence
of the Superbug: Antimicrobial Resistance in the U.S." Read
APUA's statement.
6/24/2008 APUA
issues a Press Release in conjunction with Senate hearing: "Emergence
of the Superbug: Antimicrobial Resistance in the U.S." Read
APUA's Press Release.
6/18/2008 APUA
submits a statement for consideration at the National Biodefense
Science Board meeting, June 18-20, 2008. Read
APUA's statement.
"4/29/08: APUA issues
a Press Release responding to the Pew Commission on Industrial
Farm Animal Production (PCIFAP)'s report and commending legislative
leadership in containing antibiotic resistance". Read
APUA's Press Release 4/29/08.
APUA submits a written
testimony for the FDA hearing on antimicrobial resistance 4/28/2008
[Docket No. FDA-2008-N-0225]". Read
APUA's testimony.
FAAIR
I Report: "Antibiotics in Agriculture" The Need to Improve Antimicrobial
Use in Agriculture: Ecological and Human Health Effects
For more information see APUA
Faair Report.
Introduction
by Michael Barza, Sherwood Gorbach, and Stephen J. DeVincent
Select
Findings and Conclusions by FAAIR Scientific Advisory Panel
Policy
Recommendations by FAAIR Scientific Advisory Panel
Executive
Summary: Select Findings, Conclusions, and Policy Recommendations
by The Alliance for the Prudent Use of Antibiotics
FAAIR
II Report: "Animal Antimicrobial Use Data Collection in the United
States: Methodological Options."
This project focuses on obtaining improved antibiotic usage estimates
in US food animal production to guide regulatory decision-making.
FAAIR II involves collaboration with an expert panel composed
of representatives from academia, food producer organizations,
public interest groups, veterinary professional associations,
public health agencies, and the pharmaceutical industry. Both
FAAIR and FAAIR II were supported by The Joyce Foundation.
Introduction
Deliberations
2005
Report of the Global Advisory on Antibiotic Resistance Data (GAARD):
"Global Antimicrobial Resistance Alerts and Implications"
published as a Supplement (2005;41) to Clinical Infectious
Diseases, a publication of the University Chicago Press
For more information see APUA
GAARD Press Releases.
APUA Participates in NARMS
Public Meeting
On April 10, 2007, Research Director Michael Feldgarden was an
invited public speaker at the FDA Science Board Advisory Committee
Subcommittee which provides advice to the National Antimicrobial
Resistance Monitoring System (NARMS) where he conveyed APUA's
strong support for NARMS.
Cefquinome:
when Regulation Collides with Biology by Michael Feldgarden
Request
for Oral Presentation for FDA/CVM Public Meeting
|
